UBS Maintains Neutral on Alignment Healthcare, Lowers Price Target to $9

Benzinga Newsdesk www.benzinga.com Negative 76.1%

Neg 76.1% Neu 0% Pos 0%

UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and lowers the price target from $22 to $9.